• If you are wondering whether Nova's share price still represents good value or if expectations have run ahead of reality, you are not alone.
• Nova's recent share price moves have been strong, with the stock at US$445.70 and total returns of 13.1% over 7 days, 48.1% over 30 days, 28.3% year to date, 82.0% over 1 year, 380.8% over 3 years and a very large gain over 5 years.
• These returns have put Nova firmly on many investors' radar, prompting closer attention to what is driving the story behind the price. The combination of multi year gains and recent momentum means valuation is now a key question for anyone considering the stock.
• Simply Wall St's valuation checks currently give Nova a 1 out of 6 value score. Next, we look at what different valuation methods say about the shares, then finish with a more holistic way to think about value that goes beyond any single model.

Nova scores just 1/6 on our valuation checks. See what other red flags we found in the full valuation breakdown.

Approach 1: Nova Discounted Cash Flow (DCF) Analysis

A Discounted Cash Flow, or DCF, model projects a company’s future cash flows and then discounts them back to today using a required rate of return, to estimate what the business might be worth right now.

For Nova, the model used is a 2 Stage Free Cash Flow to Equity approach, based on cash flow projections. The latest twelve month free cash flow is $228.95 million. Analyst inputs and Simply Wall St extrapolations project annual free cash flow rising to around $348.45 million in 2035, with interim projections such as $277 million in 2026 and $318.02 million in 2032, all in $.

After discounting these projected cash flows, the model arrives at an estimated intrinsic value of $83.32 per share. Compared with the current share price of US$445.70, the DCF output suggests Nova is very richly priced, with the intrinsic discount figure indicating the shares are assessed as 435.0% overvalued by this method.

Result: OVERVALUED

Our Discounted Cash Flow (DCF) analysis suggests Nova may be overvalued by 435.0%. Discover 863 undervalued stocks or create your own screener to find better value opportunities.

Approach 2: Nova Price vs Earnings

For profitable companies like Nova, the P/E ratio is a common way to think about value, because it links what you pay today directly to the earnings the business is already generating.

What counts as a “normal” P/E depends on how fast earnings are expected to grow and how risky those earnings are. Higher growth and lower perceived risk can justify a higher P/E, while slower growth or higher risk usually point to a lower, more conservative multiple.

Nova currently trades on a P/E of 53.94x. That sits above the Semiconductor industry average of 43.37x and below the peer group average of 72.44x. In other words, the stock is priced richer than the wider industry but not at the top of its peer set.

Simply Wall St’s Fair Ratio for Nova is 30.47x. This is a proprietary P/E estimate that reflects the company’s earnings growth profile, margins, risk characteristics, size and industry, rather than just a simple comparison with sector or peers. Because it blends these company specific factors, it aims to give a more tailored view of what might be a reasonable multiple.

Comparing the Fair Ratio of 30.47x with the current P/E of 53.94x, Nova screens as expensive on this metric.

Result: OVERVALUED

P/E ratios tell one story, but what if the real opportunity lies elsewhere? Discover 1445 companies where insiders are betting big on explosive growth.

Upgrade Your Decision Making: Choose your Nova Narrative

Earlier we mentioned that there is an even better way to understand valuation. Narratives on Simply Wall St let you attach your own story about Nova to the numbers by linking what you believe about its future revenue, earnings and margins to a forecast and fair value, then comparing that fair value with the current price to help you decide when to buy or sell. All of this is available within an easy tool on the Community page that updates automatically when fresh information like earnings or news arrives. A bullish Nova Narrative might lean closer to the higher fair value estimate of about US$390 with stronger AI and DRAM adoption assumptions, while a more cautious Narrative might sit nearer the lower end around US$298 with more moderate WFE expectations. The platform handles the calculations so you can focus on which story you think makes the most sense.

Do you think there's more to the story for Nova? Head over to our Community to see what others are saying!

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.